Squamous cell carcinoma of the head and neck
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Of 34 informative cases of head and neck squamous cell carcinoma, 68% of tumors showed loss of heterozygosity at chromosome 13q33-34, where the ING1 gene is located.
|
10866301 |
2000 |
Squamous cell carcinoma
|
0.160 |
GeneticVariation
|
disease |
BEFREE |
Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas.
|
10866301 |
2000 |
Malignant Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
ING1 gene mutation is uncommon in cancer, although the subcellular localisation of p33(INGb1) may have an effect on its function.
|
12835293 |
2003 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Mutational analysis of the candidate tumor suppressor gene ING1 in Indian oral squamous cell carcinoma.
|
11287275 |
2001 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Furthermore, our data indicate that patients that harbor ING1 mutations in the tumors have a higher risk to die from the disease within 5 years (50%) compared to patients with no ING1 mutation (18%).
|
15201991 |
2004 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
ING genes (ING1-5) were identified has tumor suppressor genes.
|
24333729 |
2014 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Here we present the first report that three missense mutations and three silent changes were detected in the ING1 gene in 6 of 23 tumors with allelic loss at the 13q33-34 region.
|
10866301 |
2000 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
We then determined the genomic structure of the ING1 gene and sequenced the entire coding region in 20 primary tumors showing 13q LOH and in five head and neck cancer cell lines.
|
10679922 |
2000 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Furthermore, the micron-sized MCT adjuvant was as potent as B type CpGs and clearly superior to the commonly used Alum adjuvant when total CD8<sup>+</sup>, specific p33 T cell response or tumour protection were assessed.
|
31027511 |
2019 |
Primary malignant neoplasm
|
0.090 |
GeneticVariation
|
group |
BEFREE |
ING1 gene mutation is uncommon in cancer, although the subcellular localisation of p33(INGb1) may have an effect on its function.
|
12835293 |
2003 |
Neoplasm Metastasis
|
0.060 |
GeneticVariation
|
phenotype |
BEFREE |
Our study demonstrates that overexpression of let-7b in gastric cancer can inhibit invasion and migration of gastric cancer cells through directly targeting the tumor metastasis-associated gene ING1.
|
25613480 |
2015 |
melanoma
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
p33ING1b mutations in melanoma are rare.
|
16792758 |
2006 |
melanoma
|
0.050 |
GeneticVariation
|
disease |
LHGDN |
We show that 20% of the melanoma primaries contained missense mutations in the SAP30-interacting domain and PHD finger motif of the ING1 gene with the R102L and N260S alterations observed more than once.
|
15201991 |
2004 |
Neuroblastoma
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Interestingly, a rearrangement of the ING1 gene was found in a neuroblastoma cell line, supporting its involvement in tumor development.
|
10679922 |
2000 |
Non-Small Cell Lung Carcinoma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer.
|
21286670 |
2011 |
Malignant Head and Neck Neoplasm
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
We then determined the genomic structure of the ING1 gene and sequenced the entire coding region in 20 primary tumors showing 13q LOH and in five head and neck cancer cell lines.
|
10679922 |
2000 |
Central neuroblastoma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Interestingly, a rearrangement of the ING1 gene was found in a neuroblastoma cell line, supporting its involvement in tumor development.
|
10679922 |
2000 |
Liver carcinoma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Recently, three ING1 splice variants have been cloned, but their roles in apoptosis and p53 regulation in human hepatocellular carcinoma (HCC) have not been fully elucidated.
|
19085961 |
2009 |
Head and Neck Carcinoma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
We then determined the genomic structure of the ING1 gene and sequenced the entire coding region in 20 primary tumors showing 13q LOH and in five head and neck cancer cell lines.
|
10679922 |
2000 |
Childhood Neuroblastoma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Interestingly, a rearrangement of the ING1 gene was found in a neuroblastoma cell line, supporting its involvement in tumor development.
|
10679922 |
2000 |
Alzheimer's Disease
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We discuss the functional association linking p53, IGF-1, SIRT1, and ING-1 splice variants with senescence and aging, and review a selection of splicing defects occurring in accelerated aging (progeria), vascular aging, and Alzheimer's disease.
|
28703423 |
2017 |
Colorectal Carcinoma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
No mutation of ING1 gene is found, and there are only few LOH in sporadic colorectal cancers.
|
16273637 |
2005 |
Chronic granulomatous disease
|
0.020 |
GeneticVariation
|
group |
BEFREE |
A male CGD patient with pg91(phox) deficiency exhibited a trend toward prolongation of this calcium response, whereas two other CGD patients (one with p47 and one with 67(phox) deficiencies) had normal calcium transients.
|
15527168 |
2004 |
Progeria
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We discuss the functional association linking p53, IGF-1, SIRT1, and ING-1 splice variants with senescence and aging, and review a selection of splicing defects occurring in accelerated aging (progeria), vascular aging, and Alzheimer's disease.
|
28703423 |
2017 |
Malignant neoplasm of ovary
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Thus, ING1 mutation is very rare in breast or ovarian cancers, however, repression of ING1 expression frequently accompanies tumour development of breast cancer.
|
10498868 |
1999 |